Previous Close | 42.19 |
Open | 42.01 |
Bid | 41.49 x 900 |
Ask | 41.50 x 1300 |
Day's Range | 39.71 - 42.23 |
52 Week Range | 8.34 - 53.75 |
Volume | 350,025 |
Avg. Volume | 419,688 |
Market Cap | 4.089B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Paul Dellaquila, President of Defiance ETFs, joined The Final Round to discuss the company's newly launched ETF that focuses on SPACs and how to invest and evaluate the SPAC market.
Every investor in Immunovant, Inc. (NASDAQ:IMVT) should be aware of the most powerful shareholder groups. Institutions...